Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lyell Immunopharma (LYEL)
NASDAQ:LYEL
Holding LYEL?
Track your performance easily
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 34.00K | $ 13.00K | $ 3.00K | $ 13.00K | $ 25.00K |
| Gross Profit | $ 34.00K | $ 13.00K | $ 3.00K | $ 13.00K | $ 25.00K |
| EBIT | $ -44.58M | $ -45.81M | $ -60.67M | $ -52.93M | $ -59.04M |
| EBITDA | $ -39.90M | $ -36.54M | $ -60.01M | $ -41.66M | $ -53.94M |
| Net Income Common Stockholders | $ -44.58M | $ -45.81M | $ -60.67M | $ -52.93M | $ -50.85M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 440.55M | $ 491.12M | $ 526.30M | $ 546.22M | $ 575.43M |
| Total Assets | $ 619.22M | $ 654.14M | $ 694.22M | $ 750.03M | $ 794.99M |
| Total Debt | $ 51.44M | $ 53.32M | $ 55.16M | $ 56.89M | $ 58.58M |
| Net Debt | $ -389.11M | $ -437.80M | $ -471.14M | $ -489.33M | $ -516.86M |
| Total Liabilities | $ 88.52M | $ 87.64M | $ 91.06M | $ 95.08M | $ 97.42M |
| Stockholders Equity | $ 530.70M | $ 566.50M | $ 603.16M | $ 654.95M | $ 697.57M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -35.10M | $ -38.42M | $ -42.05M | $ -40.66M | $ -37.88M |
| Operating Cash Flow | $ -35.04M | $ -38.09M | $ -42.02M | $ -40.63M | $ -37.69M |
| Investing Cash Flow | $ 1.92M | $ 45.01M | $ 21.99M | $ -100.69M | $ 99.67M |
| Financing Cash Flow | - | $ 862.00K | $ 27.00K | $ 759.00K | $ -143.00K |